Questions

2985. Deputy Denise Mitchell asked the Minister for Health if consideration will be given to adding the drug skyclarys which is used in the treatment of Friedreich's ataxia to the drugs payment scheme; and if she will make a statement on the matter. [25182/26]

3210. Deputy Denise Mitchell asked the Minister for Health if she is aware of reports that MRI machines at Beaumont Hospital are in need of repair, that some patients report having to travel by taxi to Blackrock in order to avail of PET scans; the steps she is taking to ensure such diagnostic scans are available in Beaumont; and if she will make a statement on the matter. [26477/26]

438. Deputy Denise Mitchell asked the Minister for Health the reason the HSE hairpiece contribution for those with non-cancer related medical alopecia has been reduced from €770 to €500; if she will consider reinstating the full contribution for those with non-cancer related medical alopecia; and if she will make a statement on the matter. [23151/26]

2072. Deputy Denise Mitchell asked the Minister for Health if she will intervene to ensure that the HSE prioritises a conclusion to the Skyclarys reimbursement negotiations, given that it is the only available treatment for this progressive disease and represents a clear unmet need under the National Rare Disease Strategy 2025-2030; if she believes the current delay aligns with the "equitable access" promised in the …

2170. Deputy Denise Mitchell asked the Minister for Health the financial supports that may be available to someone suffering from Parkinson’s disease who requires a mobility scooter; and if she will make a statement on the matter. [20435/26]

318. Deputy Denise Mitchell asked the Minister for Health the changes which have been made to the long-established process of automatic progression for paramedic graduates into full time employment with the National Ambulance Service; the rationale for any changes to this process; and if she will make a statement on the matter. [17743/26]

899. Deputy Denise Mitchell asked the Minister for Health if consideration will be given to making the medication Skyclarys (omaveloxolone) available to Irish Friedreich’s Ataxia patients under the current drugs reimbursement process; if she recognises the clinical necessity of this request as this drug is the only proven treatment to slow the progression of this debilitating condition; and if she will make a stateme…

1110. Deputy Denise Mitchell asked the Minister for Health for an update on the progress made in terms of the expansion of the national newborn bloodspot screening programme (NNBSP), in particular the addition of severe combined immunodeficiency and spinal muscular atrophy to the NNBSP; and if she will make a statement on the matter. [15167/26]

445. Deputy Denise Mitchell asked the Minister for Health the steps being taken to ensure that clinical guidelines and cardiovascular risk assessment tools, reflect, sex-specific differences in women's cardiovascular policies; and if she will make a statement on the matter. [7237/26]

1035. Deputy Denise Mitchell asked the Minister for Health the steps she and her Department have taken to address grievances of staff at a facility (details supplied) in Coolock, which has seen them on indefinite strike since 16 January 2026; if she and her Department will liaise with the workers and their union to come to a satisfactory agreement around pay; and if she will make a statement on the matter. [5912/26]

2414. Deputy Denise Mitchell asked the Minister for Health her plans to modify the eligibility criteria to allow single women access IVF treatment via the HSE; and if she will make a statement on the matter. [1467/26]

312. Deputy Denise Mitchell asked the Minister for Health for an update on plans for a primary healthcare centre in the Belmayne/Clongriffin area of north Dublin; and if she will make a statement on the matter. [70536/25]

494. Deputy Denise Mitchell asked the Minister for Health if there are any plans for the establishment of rapid access diagnostic clinics for pancreatic cancer, similar to those which already exist for breast, prostate and lung cancers; and if she will make a statement on the matter. [66836/25]

439. Deputy Denise Mitchell asked the Minister for Health the progress to date on the provision of a new emergency department at Beaumont Hospital; when it is envisaged construction will begin; the planned timeline for completion; when the new department will be operational; and if she will make a statement on the matter. [62371/25]

1927. Deputy Denise Mitchell asked the Minister for Health the timeline as to when the Assisted Human Reproduction Regulatory Authority will be in a position to oversee and regulate donations of embryos for the purpose of fertility treatment; if any interim measures or guidance for clinics and patients will be issued while the framework is being finalised; and if she will make a statement on the matter. [59262/25]

1928. Deputy Denise Mitchell asked the Minister for Health the progress which has been made to ensure routine testing for spinal muscular atrophy (SMA) is included in the national newborn screening programme heel-prick test; when it is envisaged that every newborn baby will be screened for SMA; and if she will make a statement on the matter. [59289/25]

2317. Deputy Denise Mitchell asked the Minister for Health the status of the health technology assessment of the muscular dystrophy drug (details supplied); if she will consider the inclusion of this drug on the drugs payment scheme; and if she will make a statement on the matter. [45581/25]

2727. Deputy Denise Mitchell asked the Minister for Health the alternatives available for workers wishing to register with CORU but find that their employer refuses to complete the necessary forms; if she plans to make it easier for workers to register for CORU in such situations where an employer is unco-operative; and if she will make a statement on the matter. [41718/25]

855. Deputy Denise Mitchell asked the Minister for Health if there are any plans to make the meningococcal B (MenB) vaccine available free of charge to older citizens; and if she will make a statement on the matter. [36177/25]

187. Deputy Denise Mitchell asked the Minister for Health to clarify if it is considered best practice that all pancreatic cancer patients, regardless of family history, receive genetic testing to identify and detect a possible inherited predisposition to such cancer in close family relatives; if she will clarify the timeline between a referral for such testing and the actual test being conducted; and if she will mak…

1407. Deputy Denise Mitchell asked the Minister for Health the status of the Hereditary Cancer Model of Care in Ireland; the funding that has been provided for this initiative and the plans for future funding; and if she will make a statement on the matter. [29534/25]

1408. Deputy Denise Mitchell asked the Minister for Health if genetic testing is yet available to close relatives of those diagnosed with pancreatic cancer in order to detect genetic mutations and aid in early diagnosis and prevention; and if she will make a statement on the matter. [29535/25]

1617. Deputy Denise Mitchell asked the Minister for Health the progress made on the approval of a vaccine injury compensation scheme; and if she will make a statement on the matter. [30547/25]

486. Deputy Denise Mitchell asked the Minister for Health the status of the development of multidisciplinary auditory processing disorder services within the CHO 9 Health Service Region in north Dublin; how these services compare with the provision of APD services statewide; and if she will make a statement on the matter. [22355/25]

487. Deputy Denise Mitchell asked the Minister for Health the efforts being made to ensure adequate auditory processing disorder assessment capacity within the HSE; and if she will make a statement on the matter. [22356/25]